Supplementary Figures 1-3 from HGF/c-Met Acts as an Alternative Angiogenic Pathway in Sunitinib-Resistant Tumors

Abstract
Supplementary Figures 1-3 from HGF/c-Met Acts as an Alternative Angiogenic Pathway in Sunitinib-Resistant Tumors